Expert Ratings For Oscar Health
Portfolio Pulse from Benzinga Insights
Over the past three months, 7 analysts have shared their insights on Oscar Health (NYSE:OSCR), with ratings ranging from bullish to bearish. The average 12-month price target has increased to $24.43, with a high estimate of $28.00 and a low estimate of $21.00. Recent analyst actions include upgrades and downgrades, reflecting changing market conditions and company performance.
June 26, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oscar Health has received mixed analyst ratings over the past three months, with an average 12-month price target of $24.43. Recent upgrades and downgrades reflect changing market conditions and company performance.
The mixed analyst ratings and increased average price target suggest a positive outlook for Oscar Health in the short term. The recent upgrades by analysts indicate confidence in the company's performance and potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100